The approval offers a once-weekly basal insulin treatment option for patients, reducing the frequency of injections.
|Articles|August 2, 2021
Pharmacy Times: Week of August 2 Lineup
This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.
Advertisement
This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week, including:
- A video interview with William Carroll, PharmD, BCPS, system vice president of pharmacy services at Rochester Regional Health, about how he has maintained his mental health during the COVID-19 pandemic.
- An article that discusses the important role pharmacists can play in identifying the early warning signs of diabetes and associated complications, which could ultimately lead to earlier opportunities to improve patient outcomes and lower overall health care costs.
- A pharmacy quiz on treatments for rheumatoid arthritis.
Advertisement
Related to this article
Mounjaro becomes the first GIP/GLP-1 receptor agonist cleared to lower MACE risk, based on the SURPASS-CVOT head-to-head trial.
Two Kidney Week 2026 abstracts show a dose-response link between cardiovascular-kidney-metabolic syndrome (CKM) stage and chronic kidney disease (CKD), while primary care clinicians cite evidence and workflow barriers.
In more than 262,000 UK Biobank participants, a 5-marker cardiometabolic score was linked to graded risk at each step toward CKM multimorbidity.
Two IDWeek 2026 studies link influenza vaccination to fewer ICU admissions in older adults and fewer emergency visits in children.
Early data suggest the 7 PCV20-added serotypes are causing a smaller share of invasive pneumococcal disease in children younger than 2 years.
In pooled CORALreef data, patients with eGFR below 60 had a 65.9% placebo-adjusted LDL-C reduction at week 24, with safety comparable to placebo.
A PharmD candidate reflects on the small, evidence-backed daily habits that helped her thrive—not just survive—through pharmacy school's most demanding years.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Flu Vaccination Linked to Fewer Severe Outcomes in Older Adults, Fewer ED Visits in Children
2
FDA Approves Bepirovirsen, First ASO for Chronic Hepatitis B
3
CKM Syndrome Stage Linked to CKD Odds, But Primary Care Hurdles Remain
4
Combined Cardiometabolic Biomarker Burden Tracks CKM Progression
5